THEMIS2
Protein THEMIS2
Also known as: C1orf38, ICB-1, THMS2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5TEJ8
- Gene
- THEMIS2
- Ensembl
- ENSG00000130775
- Chromosome
- 1
- Canonical length
- 643 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to be involved in T cell receptor signaling pathway and regulation of B cell activation. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
643 residues, UniProt reviewed canonical sequence.
>Q5TEJ8|THEMIS2
1 MEPVPLQDFV RALDPASLPR VLRVCSGVYF EGSIYEISGN ECCLSTGDLI KVTQVRLQKV
61 VCENPKTSQT MELAPNFQGY FTPLNTPQSY ETLEELVSAT TQSSKQLPTC FMSTHRIVTE
121 GRVVTEDQLL MLEAVVMHLG IRSARCVLGM EGQQVILHLP LSQKGPFWTW EPSAPRTLLQ
181 VLQDPALKDL VLTCPTLPWH SLILRPQYEI QAIMHMRRTI VKIPSTLEVD VEDVTASSRH
241 VHFIKPLLLS EVLAWEGPFP LSMEILEVPE GRPIFLSPWV GSLQKGQRLC VYGLASPPWR
301 VLASSKGRKV PRHFLVSGGY QGKLRRRPRE FPTAYDLLGA FQPGRPLRVV ATKDCEGERE
361 ENPEFTSLAV GDRLEVLGPG QAHGAQGSDV DVLVCQRLSD QAGEDEEEEC KEEAESPERV
421 LLPFHFPGSF VEEMSDSRRY SLADLTAQFS LPCEVKVVAK DTSHPTDPLT SFLGLRLEEK
481 ITEPFLVVSL DSEPGMCFEI PPRWLDLTVV KAKGQPDLPE GSLPIATVEE LTDTFYYRLR
541 KLPACEIQAP PPRPPKNQGL SKQRRHSSEG GVKSSQVLGL QQHARLPKPK AKTLPEFIKD
601 GSSTYSKIPA HRKGHRPAKP QRQDLDDDEH DYEEILEQFQ KTILocalizationUniProt · AlphaFold · HPA
Whether an antibody against THEMIS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 203 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 203 nTPM
- spleen: 118 nTPM
- appendix: 69 nTPM
- lymph node: 45 nTPM
- lung: 43 nTPM
- spinal cord: 33 nTPM
Single-cell type
- neutrophils: 378 nCPM
- monocytes: 194 nCPM
- kupffer cells: 160 nCPM
- pdcs: 156 nCPM
- macrophages: 143 nCPM
- cdc: 124 nCPM
Immune cell
- neutrophil: 500 nTPM
- non-classical monocyte: 457 nTPM
- intermediate monocyte: 442 nTPM
- classical monocyte: 404 nTPM
- total PBMC: 381 nTPM
- eosinophil: 342 nTPM
Brain region
- white matter: 41 nTPM
- medulla oblongata: 37 nTPM
- pons: 30 nTPM
- thalamus: 29 nTPM
- hypothalamus: 25 nTPM
- spinal cord: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.24
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of THEMIS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads THEMIS2 as an antibody target. Whether an autoantibody or antibody against THEMIS2 could matter depends on whether native THEMIS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
THEMIS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label THEMIS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...